Who owns Apogee Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of APGE from SEC Form 13F filings across 288 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 288 institutions disclosed 67.6M shares of Apogee Therapeutics, Inc. worth $8.93B — about 89.6% of shares outstanding; the largest disclosed holder is Venrock Adviser, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
288
13F holders
$8.93B
value, 2026 filers
89.6%
of shares outstanding (67.6M sh)
115
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of APGE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Venrock Adviser, LLC | 8.5M | $1.13B | 34.2% | 11.3% | 0.0% |
| 2 | BlackRock, Inc. | 5.5M | $730.9M | 0.0% | 7.3% | +34.8% |
| 3 | HBK INVESTMENTS L PNEW | 2.9M | $378.3M | 3.7% | 3.8% | new |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $341.4M | 0.0% | 3.4% | +2.8% |
| 5 | FMR LLC | 2.5M | $330.9M | 0.0% | 3.3% | -73.1% |
| 6 | STATE STREET CORP | 2.3M | $305.0M | 0.0% | 3% | +6.2% |
| 7 | Driehaus Capital Management LLC | 1.7M | $231.0M | 1.3% | 2.3% | -9.4% |
| 8 | GOLDMAN SACHS GROUP INC | 1.7M | $224.8M | 0.0% | 2.2% | +159.5% |
| 9 | Balyasny Asset Management L.P. | 1.7M | $221.0M | 0.3% | 2.2% | +279.6% |
| 10 | GLAZER CAPITAL, LLCNEW | 1.6M | $217.8M | 5.4% | 2.2% | new |
| 11 | Paradigm Biocapital Advisors LP | 1.6M | $209.2M | 3.9% | 2.1% | +16.9% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $202.9M | 0.0% | 2% | +285.7% |
| 13 | MILLENNIUM MANAGEMENT LLC | 1.5M | $198.0M | 0.1% | 2% | +1510.7% |
| 14 | Pentwater Capital Management LPNEW | 1.4M | $189.1M | 1.2% | 1.9% | new |
| 15 | MORGAN STANLEY | 1.4M | $188.7M | 0.0% | 1.9% | +138.9% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $174.6M | 0.0% | 1.7% | +8.0% |
| 17 | PERCEPTIVE ADVISORS LLC | 1.3M | $173.6M | 2.6% | 1.7% | -15.1% |
| 18 | Jupiter Topco LLCNEW | 1.2M | $158.4M | 0.1% | 1.6% | new |
| 19 | BANK OF AMERICA CORP /DE/ | 1.1M | $149.5M | 0.0% | 1.5% | +25.0% |
| 20 | Affinity Asset Advisors, LLC | 987,000 | $131.0M | 5.9% | 1.3% | -23.2% |
| 21 | MERCER GLOBAL ADVISORS INC /ADV | 941,283 | $124.9M | 0.2% | 1.2% | +13.2% |
| 22 | First Light Asset Management, LLC | 930,289 | $123.5M | 7.5% | 1.2% | +61.3% |
| 23 | ALLIANCEBERNSTEIN L.P. | 775,058 | $65.2M | 0.0% | 1% | -21.7% |
| 24 | T. Rowe Price Investment Management, Inc. | 762,183 | $101.2M | 0.1% | 1% | -92.6% |
| 25 | Kryger Capital LLCNEW | 742,555 | $98.6M | 5.6% | 1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.